Explore more publications!
Healthy Living Europe
Got News to Share?

Press Releases

ORYZON Receives European Medicines Agency Approval to Initiate a Phase II Study of iadademstat in Essential Thrombocythemia
Feb. 24, 2026

ORYZON Receives European Medicines Agency Approval to Initiate a Phase II Study of iadademstat in Essential Thrombocythemia

Indeterminate GlobeNewswire, Inc.
Sotera Health Delivers 20th Consecutive Year of Revenue Growth and Provides 2026 Outlook
Feb. 24, 2026

Sotera Health Delivers 20th Consecutive Year of Revenue Growth and Provides 2026 Outlook

Indeterminate GlobeNewswire, Inc.
Transcenta Therapeutics to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference
Feb. 24, 2026

Transcenta Therapeutics to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference

Indeterminate GlobeNewswire, Inc.
HydroGraph Receives US EPA and UK REACH, and EU REACH Regulatory Clearances for Commercial Scale Graphene Sales Activities
Feb. 24, 2026

HydroGraph Receives US EPA and UK REACH, and EU REACH Regulatory Clearances for Commercial Scale Graphene Sales Activities

Indeterminate GlobeNewswire, Inc.
Aventra Group Expands European Operations with AI-Driven Digital Transformation Services
Feb. 24, 2026

Aventra Group Expands European Operations with AI-Driven Digital Transformation Services

Neutral EIN Presswire
Amber Therapeutics strengthens its Board and Leadership team, opens UK headquarters and expands EU feasibility study for mixed urinary incontinence, increasing momentum towards a pivotal trial in the US
Feb. 24, 2026

Amber Therapeutics strengthens its Board and Leadership team, opens UK headquarters and expands EU feasibility study for mixed urinary incontinence, increasing momentum towards a pivotal trial in the US

Indeterminate GlobeNewswire, Inc.
AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference
Feb. 23, 2026

AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference

Indeterminate GlobeNewswire, Inc.
Hospitals Electronic Health Records Turn Data Into Better Decisions, Approaching $28.94 Billion by 2035
Feb. 23, 2026

Hospitals Electronic Health Records Turn Data Into Better Decisions, Approaching $28.94 Billion by 2035

Indeterminate GlobeNewswire, Inc.
Emerald Analysis of 25,000 Biomarker Tests Reveals Hidden Health Risks Across the UK
Feb. 23, 2026

Emerald Analysis of 25,000 Biomarker Tests Reveals Hidden Health Risks Across the UK

Neutral EIN Presswire
Liposoma Technology Strengthens Its Position as a Reference Partner for Advanced Lipid-Based Delivery Systems in Europe
Feb. 23, 2026

Liposoma Technology Strengthens Its Position as a Reference Partner for Advanced Lipid-Based Delivery Systems in Europe

Indeterminate GlobeNewswire, Inc.
Innesto Partners Strengthens Position as Leader in European Search Fund Investing for SMEs
Feb. 23, 2026

Innesto Partners Strengthens Position as Leader in European Search Fund Investing for SMEs

Neutral EIN Presswire
Minister Han with the European Commissioner for Sport on the economic and social impacts in the European Union
Feb. 23, 2026

Minister Han with the European Commissioner for Sport on the economic and social impacts in the European Union

Gov't Institution Government of Slovenia
Owner: Slovenian Government

Government of Slovenia

Gov't Institution
Owned By Slovenian Government
Year Founded 1990
Website www.vlada.si
Domain Registration Year 1998
Access Type open
Publication Location Slovenia, Ljubljana
Owner Country Slovenia

We welcome your feedback!
If you have comments or corrections, let us know.

TOMI Environmental Solutions Receives Biocidal Product Approvals in Great Britain and Northern Ireland
Feb. 23, 2026

TOMI Environmental Solutions Receives Biocidal Product Approvals in Great Britain and Northern Ireland

Indeterminate GlobeNewswire, Inc.
Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors
Feb. 23, 2026

Anavex Life Sciences Appoints Seasoned Healthcare Leader to Board of Directors

Indeterminate GlobeNewswire, Inc.
Key Opinion Leader (KOL) Panel to Discuss Acrivon’s ACR-368 Endometrial Cancer (EC) Trial during the 2026 European Society of Gynecological Oncology (ESGO) Congress
Feb. 23, 2026

Key Opinion Leader (KOL) Panel to Discuss Acrivon’s ACR-368 Endometrial Cancer (EC) Trial during the 2026 European Society of Gynecological Oncology (ESGO) Congress

Indeterminate GlobeNewswire, Inc.
Opterion Health AG Announces First Patient enrolled in Phase 1 SPARC Trial Following CTA Approval for OPT101
Feb. 23, 2026

Opterion Health AG Announces First Patient enrolled in Phase 1 SPARC Trial Following CTA Approval for OPT101

Indeterminate GlobeNewswire, Inc.
Hungary Moves to Block USD106B EU Ukraine Loan
Feb. 22, 2026

Hungary Moves to Block USD106B EU Ukraine Loan

Indeterminate MENAFN
Owner: Sawsan Dababneh

MENAFN

Indeterminate
Owned By Sawsan Dababneh through The Middle East North Africa Financial Network, Inc
Year Founded 2000
Website menafn.com
Domain Registration Year Indeterminate
Access Type open
Publication Location Jordan, Amman
Owner Country Jordan

We welcome your feedback!
If you have comments or corrections, let us know.

Healthy Snacks Market to Reach USD 129.89 Billion by 2032, Expanding at 5.8% CAGR, According to Maximize Market Research
Feb. 20, 2026

Healthy Snacks Market to Reach USD 129.89 Billion by 2032, Expanding at 5.8% CAGR, According to Maximize Market Research

Neutral EIN Presswire
argenx to Present at TD Cowen 46th Annual Healthcare Conference
Feb. 23, 2026

argenx to Present at TD Cowen 46th Annual Healthcare Conference

Indeterminate GlobeNewswire, Inc.
EU-funded project Breaking The Walls restarts in 2026 with the first major event in Italy, 19–22 March
Feb. 20, 2026

EU-funded project Breaking The Walls restarts in 2026 with the first major event in Italy, 19–22 March

Neutral EIN Presswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions